Show simple item record

dc.contributor.authorEvans, D. G.en
dc.contributor.authorHowell, Sacha Jen
dc.contributor.authorBurghel, G. J.en
dc.contributor.authorForde, C.en
dc.contributor.authorLalloo, F.en
dc.contributor.authorSmith, M. J.en
dc.contributor.authorHowell, A.en
dc.contributor.authorGandhi, A.en
dc.contributor.authorWoodward, E. R.en
dc.date.accessioned2024-10-07T07:24:54Z
dc.date.available2024-10-07T07:24:54Z
dc.date.issued2024en
dc.identifier.citationEvans DG, Howell SJ, Burghel GJ, Forde C, Lalloo F, Smith MJ, et al. Germline testing for breast cancer patients in England: illogical to prioritise grade 1 breast cancer aged 30-39 over grade 3 aged 40-49 years? Journal of medical genetics. 2024 2024 JUL 25. PubMed PMID: WOS:001279890700001. English.en
dc.identifier.pmid39054051en
dc.identifier.urihttp://hdl.handle.net/10541/627137
dc.language.isoenen
dc.titleGermline testing for breast cancer patients in England: illogical to prioritise grade 1 breast cancer aged 30-39 over grade 3 aged 40-49 years?en
dc.contributor.departmentThe Christie NHS Foundation Trust, Manchester, UKen
dc.identifier.journalJournal of Medical Geneticsen
dc.description.noteen]


This item appears in the following Collection(s)

Show simple item record